Details for Patent: RE35524
✉ Email this page to a colleague
Summary for Patent: RE35524
| Title: | Epipodophyllotoxin glucoside 4'-phosphate derivatives |
| Abstract: | Phosphate derivatives of 4'-demethylepipodophyllotoxin glucosides are novel antitumor agents and the salts thereof offer the pharmaceutical advantage of high water solubility. |
| Inventor(s): | Mark G. Saulnier, Peter D. Senter, John F. Kadow |
| Assignee: | Bristol Myers Squibb Co |
| Application Number: | US08/229,659 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent RE35524
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE35524
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 398974 | ⤷ Start Trial | |||
| Austria | A195588 | ⤷ Start Trial | |||
| Australia | 2030688 | ⤷ Start Trial | |||
| Australia | 610619 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
